BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Advarra - ECPv6.15.12.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.advarra.com X-WR-CALDESC:Events for Advarra REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20260528T110000 DTEND;TZID=America/New_York:20260528T120000 DTSTAMP:20260625T132255 CREATED:20260506T225713Z LAST-MODIFIED:20260506T225852Z UID:69850-1779966000-1779969600@www.advarra.com SUMMARY:Ensuring Operational Feasibility in Next-Generation Oncology Trials DESCRIPTION:Ensuring Operational Feasibility in Next-Generation Oncology Trials\n\n\n\n\n\nRapid advances in oncology such as cell therapies\, antibody-drug conjugates\, biomarker-driven treatments\, and increasingly adaptive trial designs (including basket\, umbrella\, and platform studies) are transforming how cancer drugs are developed. While these breakthroughs hold enormous promise\, they also introduce new operational challenges related to patient identification\, evolving protocols\, specialized sites\, complex logistics\, and trial execution across multiple cohorts and arms. \n\n\n\n\nRegister now URL:https://www.advarra.com/event/ensuring-operational-feasibility-in-next-generation-oncology-trials/ CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260527T130000 DTEND;TZID=America/New_York:20260527T140000 DTSTAMP:20260625T132255 CREATED:20260514T171208Z LAST-MODIFIED:20260514T171216Z UID:69905-1779886800-1779890400@www.advarra.com SUMMARY:Federal Public Policy Briefing: Understanding 21 CFR 50.54: When FDA-Regulated Pediatric Research Requires Federal Review DESCRIPTION:Federal Public Policy Briefing: Understanding 21 CFR 50.54: When FDA-Regulated Pediatric Research Requires Federal Review\n\n\n\n\n\nResearch involving children that poses more than minor increase over minimal risk without direct benefit requires federal review under 21 CFR 50.54/46.407\, yet sponsors\, investigators\, and IRBs frequently hesitate to pursue this pathway. This session examines why that hesitancy persists\, the regulatory challenges it creates\, and how stakeholders can better navigate federal referral to advance pediatric research while maintaining participant protections. \n\n\n\n\nRegister now URL:https://www.advarra.com/event/federal-public-policy-briefing-understanding-21-cfr-50-54/ CATEGORIES:Third-Party Webinars,Virtual,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260519T130000 DTEND;TZID=America/New_York:20260519T133000 DTSTAMP:20260625T132255 CREATED:20260415T171615Z LAST-MODIFIED:20260415T175939Z UID:69404-1779195600-1779197400@www.advarra.com SUMMARY:Launching Advarra Voice to the Site Community DESCRIPTION:Launching Advarra Voice to the Site Community\n\n\n\n\n\n\n\n\nHelp Shape the Future of Product InnovationAdvarra’s customers shape our product innovation. This webinar introduces Advarra Voice—a new\, interactive voting experience designed to give you another way to influence product development.Advarra Voice is built for all Advarra customers\, but this exclusive webinar is for OnCore and Clinical Conductor administrators and users.In this webinar\, you’ll:• see the Advarra Voice experience in action• preview upcoming CTMS and site technology innovations• vote on the features and enhancements that matter mostBy capturing your feedback\, Advarra Voice helps ensure Advarra’s solutions better meet your needs.Join us to provide your feedback on Advarra’s roadmap so that it delivers meaningful value to you and your organization. \n\n\n\nSpeaker:\n\n\n\nJames WurdemanSVP Product Lead – Research Site Solutions\, AdvarraJames Wurdeman is the Senior Vice President of Product Lead forResearch Site Solutions at Advarra. In this role\, he collaborates with Advarra’s research community to understand their challenges and translates those challenges into solution-based enhancements to our product offerings. His 17 years’ experience leading customer support and product management functions ensures Advarra can advance and optimize the day-to-day workflows of clinical research. URL:https://www.advarra.com/event/launching-advarra-voice-to-the-site-community/ CATEGORIES:Virtual,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260512T110000 DTEND;TZID=America/New_York:20260512T120000 DTSTAMP:20260625T132255 CREATED:20260420T204210Z LAST-MODIFIED:20260501T220315Z UID:69507-1778583600-1778587200@www.advarra.com SUMMARY:Webinar - AMRC The Network Advantage: Three models\, one goal. Scaling site success DESCRIPTION:Webinar – AMRC The Network Advantage: Three models\, one goal. Scaling site success\n\n\n\n\n\nJoin us for an in-depth conversation on effective strategies for growing your site within today’s evolving clinical research landscape. Hear from subject matter experts representing 3 leading site networks as they share proven approaches to expanding site business by leveraging multi-site network models. URL:https://www.advarra.com/event/webinar-amrc-the-network-advantage-three-models-one-goal-scaling-site-success/ CATEGORIES:Virtual,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260226T130000 DTEND;TZID=America/New_York:20260226T140000 DTSTAMP:20260625T132255 CREATED:20260203T204731Z LAST-MODIFIED:20260319T164306Z UID:67981-1772110800-1772114400@www.advarra.com SUMMARY:Leveraging Advarra’s Strategic Enablement Services to Improve Research Site Efficiency DESCRIPTION:Leveraging Advarra’s Strategic Enablement Services to Improve Research Site Efficiency\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nResearch sites and institutions commonly face challenges with administrative pressure across critical research workflows\, along with complexity in regulatory requirements for successful clinical study execution.  Navigating these challenges requires deep expertise and experienced staffing to support research sites with both short- and long-term needs.   Leading research sites have leveraged support from Advarra’s Strategic Enablement Services to enhance research productivity\, strengthen regulatory and billing compliance\, and optimize technology investments to ensure research studies are being conducted in the most efficient and effective way.  \n\n\n\nJoin us for an informative session to hear from your peers who have walked in your shoes and learn how they managed through the challenges we share in this dynamic industry. \n\n\n\nWe’ll explore a range of topics\, including how to: \n\n\n\n\nAccelerate coverage analysis\, budget negotiation\, and CTMS builds to improve study startup\n\n\n\nDevelop and refine policies and procedures that support improved compliance\n\n\n\nIdentify tools and processes that address infrastructure gaps\, streamline protocol activation\, and boost enrollment performance\n\n\n\nMaximize revenue recovery while minimizing compliance risk\n\n\n\nScale systems that support growth and enterprise-wide technology adoption\n\n\n\nPrepare for audits with proven inspection-readiness strategies\n\n\n\nRegister now to secure your spot. No CEUs will be provided for this event.\n\n\n\n\nRegister now to secure your spot. No CEUs will be provided for this event. \n\n\n\nWho: All Sites and Institutions \n\n\n\nDon’t miss this opportunity to prepare your organization to lead with efficiency and confidence in the years ahead. Register now! \n\n\n\nSpeakers:\n\n\n\nMark KingSVP\, Global Customer Experience & Service Delivery\, Advarra \n\n\n\nJim McDonaldSr. Manager\, Research Informatics\, Emory | Healthcare & University \n\n\n\nBarb MoskalenkoSenior Director\, Research AdministrationAscension Clinical Research Institute \n\n\n\nRobert VillanuevaDirector\, Clinical Research Management Office\, Marlene & Stewart Greenebaum Comprehensive Cancer Center University of Maryland School of Medicine URL:https://www.advarra.com/event/leveraging-advarras-strategic-enablement-services-to-improve-research-site-efficiency/ CATEGORIES:Virtual,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251215T130000 DTEND;TZID=America/New_York:20251215T140000 DTSTAMP:20260625T132255 CREATED:20251203T030128Z LAST-MODIFIED:20251203T030250Z UID:66920-1765803600-1765807200@www.advarra.com SUMMARY:Mastering Inspection Readiness for FDA’s AI Tool Elsa DESCRIPTION:Mastering Inspection Readiness for FDA’s AI Tool Elsa URL:https://www.advarra.com/event/mastering-inspection-readiness-for-fdas-ai-tool-elsa/ CATEGORIES:Third-Party Webinars,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251204T130000 DTEND;TZID=America/New_York:20251204T140000 DTSTAMP:20260625T132255 CREATED:20251118T165850Z LAST-MODIFIED:20251127T010330Z UID:66661-1764853200-1764856800@www.advarra.com SUMMARY:Transform Your Site Operations: Optimization Strategies to Maximize Performance DESCRIPTION:Transform Your Site Operations: Optimization Strategies to Maximize Performance\n\n\n\n\n\n\n\n\nSite networks and individual research sites of all sizes strive to grow\, but often are faced with limited budgets and lean staffing. Meeting rising operational demands while maintaining business sustainability and business growth is a challenge. To succeed\, organizations must focus on operational efficiency through stronger team alignment\, streamlined processes\, optimized technology\, and regulatory expertise.This session features industry experts who will share how research sites can optimize operations without compromising scientific rigor\, quality\, or patient care. Explore practical approaches to technology optimization\, cross-functional alignment\, and sponsor engagement that drive sustainable performance.– Gain insights on improving operational efficiency and reducing study start-up time– Discuss how to make the most of your CTMS and other technology for greater efficiency– Explore strategies to enhance collaboration across teams and with sponsorsDon’t miss this opportunity to prepare your organization to lead with efficiency and confidence in the years ahead. Register now!Moderator:Christine Senn\, Senior Vice President\, Head of Site-Sponsor Innovation\, AdvarraPanelists:Jennifer Byrne\, Founder\, Chief Executive Officer and Board Director\, Javara URL:https://www.advarra.com/event/transform-your-site-operations-optimization-strategies-to-maximize-performance/ CATEGORIES:Virtual,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251016T110000 DTEND;TZID=America/New_York:20251016T120000 DTSTAMP:20260625T132255 CREATED:20250922T161059Z LAST-MODIFIED:20250922T161103Z UID:65822-1760612400-1760616000@www.advarra.com SUMMARY:Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research DESCRIPTION:Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research\n\n\n\n\n\n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances oncology research\, we’re partnering with Fierce Pharma to explore how to overcome administrative and operational barriers in clinical research. \n\n\n\n\n\nOncology research sites are under growing pressure. Trial protocols are more and more complex\, administrative demands are increasing\, and staffing remains a persistent challenge. These issues slow study start-up\, limit patient access\, and strain the teams responsible for delivering research. \n\n\n\n In this webinar\, leaders from cancer centers and biopharma companies will discuss the operational and institutional hurdles sites face and what can be done to address them. The panel will explore practical strategies to reduce burden\, improve collaboration\, and create a better experience for research staff and patients alike. \n\n\n\n\n\nKey Takeaways\n\n\n\n\nThe most pressing administrative and operational challenges facing oncology sites\n\n\n\nHow cancer centers are working to streamline processes and improve site capacity\n\n\n\nWhat sponsors can do to reduce site burden and better align with oncology research site needs\n\n\n\nWays to improve the day-to-day experience for site staff without compromising quality\n\n\n\nWhy enabling site success is essential to expanding access and accelerating research\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\nSean CunninghamRegional Director\, Americas – Study Site EngagementTakeda Pharmaceuticals \n\n\n\n\n\nMeredith HightowerDirector\, Strategic Site Partnerships\, Clinical Field Excellence\, CSMAbbVie \n\n\n\nSara MoelleringDirector of Clinical Research OperationsUniversity of Chicago \n\n\n\nSara RaboinPhDDirector of Operations Yale Cancer Center \n\n\n\nChristine SennSenior Vice President\, Head of Site-Sponsor InnovationAdvarra URL:https://www.advarra.com/event/enabling-oncology-site-success-overcoming-administrative-and-operational-barriers-to-advance-cancer-research/ CATEGORIES:Third-Party Webinars,Webinar ATTACH;FMTTYPE=image/png:https://www.advarra.com/wp-content/uploads/Fierce-Pharma-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250821T130000 DTEND;TZID=America/New_York:20250821T133000 DTSTAMP:20260625T132255 CREATED:20250814T223819Z LAST-MODIFIED:20250814T224057Z UID:65385-1755781200-1755783000@www.advarra.com SUMMARY:Live Demo: Introducing Site-Facing SSU Milestone Tracking DESCRIPTION:Live Demo: Introducing Site-Facing SSU Milestone Tracking\n\n\n\n\n\n\n\n\nAdvarra’s Study Collaboration solution’s newest release redefines how clinical trial stakeholders coordinate during study startup. With the introduction of guided site journeys\, study startup milestone tracking is extended beyond a sponsor and CRO-only view\, that empowers sites to manage their startup responsibilities in sync with the study team. \n\n\n\nJoin us for a live\, 30-minute demo on August 21 at 1pm ET to see guided site journeys in action. URL:https://www.advarra.com/event/live-demo-introducing-site-facing-ssu-milestone-tracking/ CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250807T120000 DTEND;TZID=America/New_York:20250807T120000 DTSTAMP:20260625T132255 CREATED:20250814T221801Z LAST-MODIFIED:20250814T222221Z UID:65379-1754568000-1754568000@www.advarra.com SUMMARY:Improving Clinical Tech Adoption: Site-Centric Approaches DESCRIPTION:Improving Clinical Tech Adoption: Site-Centric Approaches\n\n\n\n\n\n\n\n\nSponsors invest heavily in study technology to drive efficiency and oversight\, but adoption at the site level often lags\, stalling the very benefits these systems promise. This webinar offers a unique opportunity for sponsors and CROs to hear directly from site professionals and sponsor peers who navigate and implement sponsor-deployed technologies every day. Through real-world perspectives\, this webinar will explore what helps — or hinders — site adoption\, and how sponsors can better evaluate\, implement and support study systems with site success in mind. \n\n\n\nJoin the featured speakers to: \n\n\n\n\nHear candid perspectives from site professionals on the real challenges of adopting sponsor-deployed technology\n\n\n\nLearn how sponsor-CRO collaboration can directly influence technology success at the site level\n\n\n\nUnderstand what makes study systems more intuitive — and what leads to frustration or failure\n\n\n\nRegister now to explore how study technology can be optimized for real-world site adoption and long-term success.\n\n\n\n\n\n\nKey Takeaways\n\n\n\nAttendees will gain insights to: \n\n\n\n\nIdentify and address the key barriers that prevent sites from adopting sponsor-deployed study technologies\n\n\n\nApply proven strategies to evaluate\, implement and support study systems with site usability and efficiency in mind\n\n\n\nFacilitate and incorporate direct site feedback to refine technology rollouts and improve long-term adoption and engagement URL:https://www.advarra.com/event/from-ethics-to-evidence-applying-real-world-data-in-oncology-trials-2/ CATEGORIES:Third-Party Webinars,Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250623T130000 DTEND;TZID=America/New_York:20250623T140000 DTSTAMP:20260625T132255 CREATED:20250603T162926Z LAST-MODIFIED:20250603T165739Z UID:64566-1750683600-1750687200@www.advarra.com SUMMARY:From Ethics to Evidence: Applying Real-World Data in Oncology Trials DESCRIPTION:From Ethics to Evidence: Applying Real-World Data in Oncology Trials\n\n\n\n\n\n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances oncology research\, we’re partnering with Fierce Pharma to explore how to ethically and effectively incorporate RWD into oncology clinical research. \n\n\n\n\n\nReal-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design\, support regulatory submissions\, and demonstrate real-world value. From generating external control arms to identifying patient cohorts and uncovering long-term safety signals\, RWD offers strategic advantages across the development lifecycle. But as the stakes grow\, so does the ethical responsibility to use RWD with transparency\, fairness\, and patient-centered rigor.This webinar will explore how to ethically and effectively incorporate RWD into oncology clinical research. Industry leaders and experts will share insights on navigating consent\, bias\, and data provenance—while aligning with regulatory expectations and building confidence in research practices. \n\n\n\n\n\nKey Takeaways\n\n\n\n\nHow RWD can be used to improve oncology clinical trial design and operations\n\n\n\nEthical considerations around patient privacy\, informed consent\, and data provenance—and strategies to align scientific\, ethical\, and reputational goals in trial design\n\n\n\nFDA\, EMA\, and global guidance on the responsible use of RWD\n\n\n\nDesigned for R&D\, clinical strategy\, and regulatory leaders\, this session offers a practical framework for building responsible\, high-impact RWD programs in oncology research.\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\nSean CunninghamRegional Director\, Americas – Study Site EngagementTakeda Pharmaceuticals \n\n\n\n\n\nMeredith HightowerDirector\, Strategic Site Partnerships\, Clinical Field Excellence\, CSMAbbVie \n\n\n\nSara MoelleringDirector of Clinical Research OperationsUniversity of Chicago \n\n\n\nSara RaboinPhDDirector of Operations Yale Cancer Center URL:https://www.advarra.com/event/from-ethics-to-evidence-applying-real-world-data-in-oncology-trials/ CATEGORIES:Third-Party Webinars,Webinar ATTACH;FMTTYPE=image/png:https://www.advarra.com/wp-content/uploads/Fierce-Pharma-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250415T120000 DTEND;TZID=America/New_York:20250415T130000 DTSTAMP:20260625T132255 CREATED:20250227T203616Z LAST-MODIFIED:20250227T204526Z UID:62721-1744718400-1744722000@www.advarra.com SUMMARY:Accelerating Study Start-Up to Improve Research Site Success DESCRIPTION:Timelines for study start-up affect everything from budgets and drug pricing to a site’s ability to secure trials. This webinar will provide actionable strategies to streamline start-up processes\, accelerate regulatory approvals\, and optimize patient recruitment. By adopting these best practices\, sites can reduce delays\, improve trial timelines\, and strengthen their competitive edge. \n\n\n\nLearning Objectives: \n\n\n\n\nDiscuss the importance of start-up speed in clinical research and its direct impact on trial timelines and success.\n\n\n\nIntegrate insights into actionable strategies and best practices to accelerate start-up processes and streamline regulatory approvals.\n\n\n\nReview tactics to leverage accelerated start-up phases to enhance efficiency\, minimize delays\, and optimize patient recruitment.\n\n\n\n\n\n\n\n\nFeaturing\n\n\n\nChristine SennSenior Vice President\, Site-Sponsor Innovation\, Advarra URL:https://www.advarra.com/event/accelerating-study-start-up-to-improve-research-site-success/ LOCATION:Virtual CATEGORIES:Third-Party Webinars ATTACH;FMTTYPE=image/jpeg:https://www.advarra.com/wp-content/uploads/scrs_webinar.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250410T130000 DTEND;TZID=America/New_York:20250410T140000 DTSTAMP:20260625T132255 CREATED:20250327T162239Z LAST-MODIFIED:20250327T163251Z UID:63520-1744290000-1744293600@www.advarra.com SUMMARY:Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential DESCRIPTION:Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential\n\n\n\n\n\n\n\n \n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances cancer research\, we’re partnering with Fierce Pharma to explore how just-in-time (JIT) oncology trials can accelerate research\, reduce costs\, and expand patient access to cutting-edge treatments.  \n\n\n\nLearning Objectives: \n\n\n\n\nAccelerating patient access through data-driven pre-screening and site partnerships \n\n\n\nOptimizing sponsor-site-IRB collaboration for seamless trial activation \n\n\n\nOvercoming operational hurdles with pre-negotiated agreements and standardized processes \n\n\n\nBalancing speed and quality in real-world JIT oncology trials \n\n\n\n\nFeaturing\n\n\n\nChristine SennSenior Vice President\, Site-Sponsor Innovation\, Advarra URL:https://www.advarra.com/event/making-oncology-trials-work/ CATEGORIES:Third-Party Webinars ATTACH;FMTTYPE=image/jpeg:https://www.advarra.com/wp-content/uploads/1742490323176-e1743092528809.jpg END:VEVENT END:VCALENDAR